US Stock MarketDetailed Quotes

PHAR Pharming Group

Watchlist

8.510
0.0000.00%

Trading Jul 19 15:57 ET

573.10MMarket Cap-53187P/E (TTM)

Pharming Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

66.44%-7.65M

-177.04%-17.3M

121.15%11.58M

-72.05%3.53M

-340.62%-9.62M

-3,841.38%-22.79M

-40.65%22.46M

-67.14%5.24M

129.76%12.62M

-57.27%4M

Net income from continuing operations

0.30%-16.62M

-180.15%-12.01M

88.77%-2.03M

-64.36%3.31M

-82.69%3.39M

-493.91%-16.67M

-35.06%14.99M

-1,143.39%-18.08M

602.42%9.28M

170.42%19.56M

Operating gains losses

57.82%535K

-101.12%-20.06M

-96.22%66K

11.24%485K

-66.28%-20.95M

-23.13%339K

-1,134.41%-9.97M

834.45%1.75M

415.94%436K

-3,837.19%-12.6M

Depreciation and amortization

156.76%5.92M

20.75%15.93M

8.36%7.56M

48.59%2.9M

52.53%3.16M

5.30%2.31M

-32.75%13.19M

-45.29%6.97M

-16.86%1.95M

-15.56%2.07M

Other non cash items

-74.74%560K

823.58%4.33M

-38.86%2.89M

21.80%-1.27M

126.78%494K

219.90%2.22M

92.69%-598K

256.45%4.72M

45.10%-1.62M

-133.89%-1.85M

Change In working capital

91.42%-1.05M

-4,282.69%-16.96M

-132.85%-1.38M

-290.40%-4.56M

175.97%1.2M

-125.07%-12.21M

92.20%-387K

209.78%4.21M

-19.99%2.4M

78.58%-1.57M

-Change in receivables

240.43%7.46M

-884.22%-18.54M

-566.25%-5.64M

-281.80%-7.36M

84.23%-226K

-263.41%-5.31M

-60.05%2.36M

-57.22%1.21M

-14.57%4.05M

68.92%-1.43M

-Change in inventory

115.12%877K

3.88%-14.43M

62.35%-3.32M

-193.62%-396K

-13.74%-4.92M

-152.55%-5.8M

-144.04%-15.02M

-298.73%-8.82M

153.48%423K

-70.02%-4.32M

-Change in payables and accrued expense

-677.37%-9.41M

35.32%16.23M

-30.44%8.15M

239.20%3.24M

42.35%6.04M

26.38%-1.21M

330.93%11.99M

3,551.09%11.72M

-139.61%-2.33M

892.16%4.25M

-Change in other working capital

-76.07%28K

-179.12%-216K

-656.73%-579K

-118.58%-47K

557.81%293K

685.00%117K

-41.54%273K

-75.53%104K

1,305.56%253K

-118.55%-64K

Cash from discontinued investing activities

Operating cash flow

66.44%-7.65M

-177.04%-17.3M

121.15%11.58M

-72.04%3.53M

-340.65%-9.62M

-3,841.38%-22.79M

-40.65%22.46M

-67.14%5.24M

129.76%12.62M

-57.27%4M

Investing cash flow

Cash flow from continuing investing activities

408.84%664K

-2,530.73%-129.39M

-879.45%-3.91M

-48,750.34%-145.57M

217.58%20.31M

42.67%-215K

124.98%5.32M

93.49%-399K

96.00%-298K

223.93%6.4M

Capital expenditure reported

62.79%-80K

-4.43%-1.44M

0.33%-304K

57.02%-147K

-47.98%-771K

-3.37%-215K

87.19%-1.38M

90.72%-305K

83.03%-342K

85.03%-521K

Net PPE purchase and sale

--1.97M

----

--0

----

Net intangibles purchase and sale

----

95.51%-27K

-400.00%-50K

-90.34%23K

----

89.94%-601K

99.65%-10K

128.07%238K

48.36%-662K

Net business purchase and sale

----

--0

----

--7.3M

---84K

---194K

----

Net investment purchase and sale

---1.23M

---149.2M

---3.75M

----

--0

----

Net other investing changes

----

--21.28M

--199K

--0

----

Cash from discontinued investing activities

Investing cash flow

408.84%664K

-2,530.73%-129.39M

-879.45%-3.91M

-48,750.34%-145.57M

217.58%20.31M

42.67%-215K

124.98%5.32M

93.49%-399K

96.00%-298K

223.93%6.4M

Financing cash flow

Cash flow from continuing financing activities

6.05%-2.47M

79.14%-1.04M

-466.91%-1.02M

372.92%5.24M

-482.93%-2.63M

8.97%-2.63M

82.17%-4.98M

229.30%278K

29.41%-1.92M

98.01%-451K

Net issuance payments of debt

-0.91%-1.32M

-54.82%-5.13M

-38.12%-1.28M

-61.44%-1.28M

-59.85%-1.26M

-62.58%-1.31M

-2.92%-3.31M

-24.97%-926K

7.81%-791K

26.03%-787K

Cash dividends paid

--0

Proceeds from stock option exercised by employees

27.19%884K

256.55%8.13M

-78.13%253K

944.74%8.55M

---1.36M

--695K

-51.65%2.28M

--1.16M

--818K

----

Cash from discontinued financing activities

Financing cash flow

6.05%-2.47M

79.14%-1.04M

-466.91%-1.02M

372.92%5.24M

-482.93%-2.63M

8.97%-2.63M

82.17%-4.98M

229.30%278K

29.41%-1.92M

98.01%-451K

Net cash flow

Beginning cash position

-70.22%61.74M

8.03%207.34M

-71.04%54.65M

1.27%192.37M

-2.58%184.78M

8.03%207.34M

-6.45%191.92M

2.93%188.7M

0.88%189.96M

-8.20%189.67M

Current changes in cash

63.11%-9.45M

-747.96%-147.73M

30.02%6.65M

-1,415.71%-136.81M

-18.93%8.06M

-865.35%-25.63M

299.82%22.8M

-46.67%5.11M

322.13%10.4M

153.93%9.94M

Effect of exchange rate changes

-112.87%-395K

128.83%2.13M

-96.75%439K

92.18%-912K

95.16%-467K

657.53%3.07M

-304.44%-7.38M

1,466.16%13.53M

-3,812.42%-11.66M

-8,641.59%-9.65M

End cash Position

-71.92%51.89M

-70.22%61.74M

-71.04%54.65M

1.27%192.37M

-2.58%184.78M

8.03%207.34M

2.93%188.7M

0.88%189.96M

Free cash flow

66.40%-7.73M

-191.63%-18.77M

128.58%11.25M

-72.99%3.38M

-469.17%-10.39M

-9,929.06%-23M

-3.05%20.48M

-49.82%4.92M

376.10%12.51M

-38.74%2.82M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	66.44%-7.65M	-177.04%-17.3M	121.15%11.58M	-72.05%3.53M	-340.62%-9.62M	-3,841.38%-22.79M	-40.65%22.46M	-67.14%5.24M	129.76%12.62M	-57.27%4M
Net income from continuing operations	0.30%-16.62M	-180.15%-12.01M	88.77%-2.03M	-64.36%3.31M	-82.69%3.39M	-493.91%-16.67M	-35.06%14.99M	-1,143.39%-18.08M	602.42%9.28M	170.42%19.56M
Operating gains losses	57.82%535K	-101.12%-20.06M	-96.22%66K	11.24%485K	-66.28%-20.95M	-23.13%339K	-1,134.41%-9.97M	834.45%1.75M	415.94%436K	-3,837.19%-12.6M
Depreciation and amortization	156.76%5.92M	20.75%15.93M	8.36%7.56M	48.59%2.9M	52.53%3.16M	5.30%2.31M	-32.75%13.19M	-45.29%6.97M	-16.86%1.95M	-15.56%2.07M
Other non cash items	-74.74%560K	823.58%4.33M	-38.86%2.89M	21.80%-1.27M	126.78%494K	219.90%2.22M	92.69%-598K	256.45%4.72M	45.10%-1.62M	-133.89%-1.85M
Change In working capital	91.42%-1.05M	-4,282.69%-16.96M	-132.85%-1.38M	-290.40%-4.56M	175.97%1.2M	-125.07%-12.21M	92.20%-387K	209.78%4.21M	-19.99%2.4M	78.58%-1.57M
-Change in receivables	240.43%7.46M	-884.22%-18.54M	-566.25%-5.64M	-281.80%-7.36M	84.23%-226K	-263.41%-5.31M	-60.05%2.36M	-57.22%1.21M	-14.57%4.05M	68.92%-1.43M
-Change in inventory	115.12%877K	3.88%-14.43M	62.35%-3.32M	-193.62%-396K	-13.74%-4.92M	-152.55%-5.8M	-144.04%-15.02M	-298.73%-8.82M	153.48%423K	-70.02%-4.32M
-Change in payables and accrued expense	-677.37%-9.41M	35.32%16.23M	-30.44%8.15M	239.20%3.24M	42.35%6.04M	26.38%-1.21M	330.93%11.99M	3,551.09%11.72M	-139.61%-2.33M	892.16%4.25M
-Change in other working capital	-76.07%28K	-179.12%-216K	-656.73%-579K	-118.58%-47K	557.81%293K	685.00%117K	-41.54%273K	-75.53%104K	1,305.56%253K	-118.55%-64K
Cash from discontinued investing activities
Operating cash flow	66.44%-7.65M	-177.04%-17.3M	121.15%11.58M	-72.04%3.53M	-340.65%-9.62M	-3,841.38%-22.79M	-40.65%22.46M	-67.14%5.24M	129.76%12.62M	-57.27%4M
Investing cash flow
Cash flow from continuing investing activities	408.84%664K	-2,530.73%-129.39M	-879.45%-3.91M	-48,750.34%-145.57M	217.58%20.31M	42.67%-215K	124.98%5.32M	93.49%-399K	96.00%-298K	223.93%6.4M
Capital expenditure reported	62.79%-80K	-4.43%-1.44M	0.33%-304K	57.02%-147K	-47.98%-771K	-3.37%-215K	87.19%-1.38M	90.72%-305K	83.03%-342K	85.03%-521K
Net PPE purchase and sale	--1.97M	----	----	----	----	--0	----	----	----	----
Net intangibles purchase and sale	----	95.51%-27K	-400.00%-50K	-90.34%23K	----	----	89.94%-601K	99.65%-10K	128.07%238K	48.36%-662K
Net business purchase and sale	----	--0	--0	--0	----	----	--7.3M	---84K	---194K	----
Net investment purchase and sale	---1.23M	---149.2M	---3.75M	----	----	--0	--0	--0	----	----
Net other investing changes	----	--21.28M	--199K	--0	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	408.84%664K	-2,530.73%-129.39M	-879.45%-3.91M	-48,750.34%-145.57M	217.58%20.31M	42.67%-215K	124.98%5.32M	93.49%-399K	96.00%-298K	223.93%6.4M
Financing cash flow
Cash flow from continuing financing activities	6.05%-2.47M	79.14%-1.04M	-466.91%-1.02M	372.92%5.24M	-482.93%-2.63M	8.97%-2.63M	82.17%-4.98M	229.30%278K	29.41%-1.92M	98.01%-451K
Net issuance payments of debt	-0.91%-1.32M	-54.82%-5.13M	-38.12%-1.28M	-61.44%-1.28M	-59.85%-1.26M	-62.58%-1.31M	-2.92%-3.31M	-24.97%-926K	7.81%-791K	26.03%-787K
Cash dividends paid	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Proceeds from stock option exercised by employees	27.19%884K	256.55%8.13M	-78.13%253K	944.74%8.55M	---1.36M	--695K	-51.65%2.28M	--1.16M	--818K	----
Cash from discontinued financing activities
Financing cash flow	6.05%-2.47M	79.14%-1.04M	-466.91%-1.02M	372.92%5.24M	-482.93%-2.63M	8.97%-2.63M	82.17%-4.98M	229.30%278K	29.41%-1.92M	98.01%-451K
Net cash flow
Beginning cash position	-70.22%61.74M	8.03%207.34M	-71.04%54.65M	1.27%192.37M	-2.58%184.78M	8.03%207.34M	-6.45%191.92M	2.93%188.7M	0.88%189.96M	-8.20%189.67M
Current changes in cash	63.11%-9.45M	-747.96%-147.73M	30.02%6.65M	-1,415.71%-136.81M	-18.93%8.06M	-865.35%-25.63M	299.82%22.8M	-46.67%5.11M	322.13%10.4M	153.93%9.94M
Effect of exchange rate changes	-112.87%-395K	128.83%2.13M	-96.75%439K	92.18%-912K	95.16%-467K	657.53%3.07M	-304.44%-7.38M	1,466.16%13.53M	-3,812.42%-11.66M	-8,641.59%-9.65M
End cash Position	-71.92%51.89M	-70.22%61.74M	-70.22%61.74M	-71.04%54.65M	1.27%192.37M	-2.58%184.78M	8.03%207.34M	8.03%207.34M	2.93%188.7M	0.88%189.96M
Free cash flow	66.40%-7.73M	-191.63%-18.77M	128.58%11.25M	-72.99%3.38M	-469.17%-10.39M	-9,929.06%-23M	-3.05%20.48M	-49.82%4.92M	376.10%12.51M	-38.74%2.82M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall